Bionano Genomics, Inc. (BNGO) stock
BNGONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3082% below fair value
$0.98+0.02 (+2.50%)
Close on Nov 18, 2026Market cap $11.49MP/E –Yield –
Bionano Genomics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Bionano Genomics's revenue for the twelve months ending Jun 30, 2026 was $30.18M, up 10.0% year over year. For fiscal 2025 it was $28.51M, down 7.4% from the year before. The highest annual figure on record is $36.12M in fiscal 2023.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $28.51M | -7.4% |
| FY2024 | Dec 31, 2024 | $30.78M | -14.8% |
| FY2023 | Dec 31, 2023 | $36.12M | +29.9% |
| FY2022 | Dec 31, 2022 | $27.80M | +54.6% |
| FY2021 | Dec 31, 2021 | $17.98M | +111.5% |
| FY2020 | Dec 31, 2020 | $8.50M | -16.1% |
| FY2019 | Dec 31, 2019 | $10.13M | -15.6% |
| FY2018 | Dec 31, 2018 | $12.00M | +26.3% |
| FY2017 | Dec 31, 2017 | $9.51M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $8.17M | +21.4% |
| Q1 FY2026 | Mar 31, 2026 | $6.69M | +3.6% |
| Q4 FY2025 | Dec 31, 2025 | $7.95M | -2.6% |
| Q3 FY2025 | Sep 30, 2025 | $7.37M | +21.3% |
| Q2 FY2025 | Jun 30, 2025 | $6.73M | -13.4% |
| Q1 FY2025 | Mar 31, 2025 | $6.46M | -26.4% |
| Q4 FY2024 | Dec 31, 2024 | $8.16M | -23.9% |
| Q3 FY2024 | Sep 30, 2024 | $6.07M | -34.8% |
| Q2 FY2024 | Jun 30, 2024 | $7.77M | -10.3% |
| Q1 FY2024 | Mar 31, 2024 | $8.77M | +18.3% |
| Q4 FY2023 | Dec 31, 2023 | $10.72M | +30.5% |
| Q3 FY2023 | Sep 30, 2023 | $9.32M | +29.0% |
| Q2 FY2023 | Jun 30, 2023 | $8.66M | +29.9% |
| Q1 FY2023 | Mar 31, 2023 | $7.42M | +30.2% |
| Q4 FY2022 | Dec 31, 2022 | $8.22M | +30.4% |
| Q3 FY2022 | Sep 30, 2022 | $7.22M | +55.1% |
| Q2 FY2022 | Jun 30, 2022 | $6.67M | +73.0% |
| Q1 FY2022 | Mar 31, 2022 | $5.70M | +79.8% |
| Q4 FY2021 | Dec 31, 2021 | $6.30M | +57.9% |
| Q3 FY2021 | Sep 30, 2021 | $4.66M | +112.0% |
| Q2 FY2021 | Jun 30, 2021 | $3.86M | +226.2% |
| Q1 FY2021 | Mar 31, 2021 | $3.17M | +178.9% |
| Q4 FY2020 | Dec 31, 2020 | $3.99M | +43.1% |
| Q3 FY2020 | Sep 30, 2020 | $2.20M | -33.7% |
| Q2 FY2020 | Jun 30, 2020 | $1.18M | -45.7% |
| Q1 FY2020 | Mar 31, 2020 | $1.14M | -38.7% |
| Q4 FY2019 | Dec 31, 2019 | $2.79M | -30.5% |
| Q3 FY2019 | Sep 30, 2019 | $3.31M | +17.1% |
| Q2 FY2019 | Jun 30, 2019 | $2.18M | -35.8% |
| Q1 FY2019 | Mar 31, 2019 | $1.85M | +4.8% |
| Q4 FY2018 | Dec 31, 2018 | $4.01M | +41.1% |
| Q3 FY2018 | Sep 30, 2018 | $2.83M | +3.1% |
| Q2 FY2018 | Jun 30, 2018 | $3.39M | +54.4% |
| Q1 FY2018 | Mar 31, 2018 | $1.77M | +2.8% |
| Q4 FY2017 | Dec 31, 2017 | $2.85M | – |
| Q3 FY2017 | Sep 30, 2017 | $2.74M | – |
| Q2 FY2017 | Jun 30, 2017 | $2.20M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.72M | – |
See a number that looks wrong?